Dividends & Buybacks ·
Enlivex Ltd. announced a 1-for-15 reverse stock split of its ordinary shares, effective July 9, 2026
ENLVEnlivex Ltd.
Enlivex Ltd. announced a 1-for-15 reverse stock split of its ordinary shares, effective July 9, 2026. The split reduces the number of authorized ordinary shares from 2,375,000,000 to 158,333,334 and increases the par value per share from NIS 0.40 to NIS 6.00. Issued and outstanding shares will decrease from 252,480,222 to approximately 16,832,015. Fractional shares will be rounded up to the nearest whole share. The company operates in the medical technology industry, developing automated systems for the production of personalized medicine.